Stock Updates

Today’s Top Gainers in the Market Sanofi (NYSE:SNY) from Healthcare

Today’s top gainers include the company Sanofi (NYSE:SNY) which is in the industry Drug Manufacturers – Major, gaining -0.46% today. In the last week its performance is 1.68%, and 0.43% for the past quarter. Currently, Sanofi, SNY has a target price of 52, so today’s gain of -0.46% is a significant step towards its target price. The GAP today is therefore -0.02%.

Sanofi (NYSE:SNY), has a market cap of 105811.02, and is based in France. Insider ownership is at 16.40%, and institutional ownership is 9.70%.

At the current price of 41.04, it has a dividend yield of 4.03%, and its target price is 52. This is with a profit margin of *TBA, and total debt/equity of *TBA. Sanofi (NYSE:SNY) has a P/E of 21.99, as well as a forward P/E of 13.03.

With a current EPS of 1.88, and a forecasted EPS growth for next year at 0.16%,Sanofi (NYSE:SNY) has had a EPS growth for the past five years at -4.40%. For the next five years EPS growth is projected to be 7.10%.

Performance for the year is -10.86%. Since its IPO date on 07/01/2002, the total performance to date is 0.74%.

Volume today for Sanofi (NYSE:SNY), is 229293, while its average volume is 2047.2. Whilst the total gain today was -0.46%, it did have a day high of -2.89%.

Volatility for this week has been at 1.54%, and 1.73% for the month. The 52-week low for Sanofi, SNY has been 13.65%, while the 52-week-high has reached -22.21%.

Looking at its return of investments, which is 6.50%, and its return on assets is *TBA. Sanofi (NYSE:SNY) has an operating margin of *TBA. With a sales growth of -3.60% quarter over quarter. Bearing in mind that Sanofi, SNY is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.

So what is the value of Sanofi? Well its PEG is 3.1, and the P/S is 2.76, along with a P/B of 1.68. Meanwhile it has a p/cash of *TBA.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment